Interse

Interse is a biotechnology company dedicated to decoding the intercellular proteome, also known as the secretome, to identify novel therapeutic targets and biomarkers. By mapping the complex network of proteins secreted by cells, the company aims to understand how cells communicate in disease states such as cancer and inflammation. Their proprietary platform enables high-resolution analysis of secreted proteins that were previously difficult to capture and quantify. Interse leverages these insights to develop a pipeline of precision medicines across multiple therapeutic areas. The company is based in Cambridge, Massachusetts, and focuses on the "dark matter" of the proteome to unlock new biological pathways.